Qu, Feng
Gu, Yue
Wang, Qizhi
He, Mingzhe
Zhou, Fang
Sun, Jianguo
Wang, Guangji
Peng, Ying https://orcid.org/0000-0002-6416-5512
Funding for this research was provided by:
the National Key New Drug Creation Special Program of China (2017ZX09304021)
the Drug Innovation Major Project (2018ZX09711001)
the National Natural Science Foundation of China (81703608)
the Jiangsu Province Natural Science Project (BK20170741)
Nanjing Medical Science and Technique Development Foundation (QRX17049)
Article History
Received: 20 November 2019
Accepted: 17 January 2020
First Online: 1 February 2020
Compliance with ethical standards
:
: Feng Qu declares that he has no conflict of interest. Yue Gu declares that she has no conflict of interest. Qizhi Wang declares that he has no conflict of interest. Mingzhe He declares that he has no conflict of interest. Zhou Fang declares that she has no conflict of interest. Jianguo Sun declares that he has no conflict of interest. Guangji Wang declares that he has no conflict of interest. Ying Peng declares that she has no conflict of interest.
: This article does not contain any studies with human participants. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: For this type of study, informed consent is not required.